The advent of PSA testing has led to concern that prostate cancer is being over diagnosed with consequent treatment of otherwise harmless tumors, resulting in some centers initiating active monitoring protocols. In this Viewpoint, the authors examine the evidence and argue that early intervention is favorable to active monitoring and delayed treatment.
- Stacy Loeb
- William J Catalona
